Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-009504
Filing Date
2022-02-14
Accepted
2022-02-14 18:57:52
Documents
2
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4008
2 POA DOCUMENT poa.txt EX-24 3210
  Complete submission text file 0001209191-22-009504.txt   8665
Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Brockstedt Dirk G. (Reporting) CIK: 0001635616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 22636149

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations